Kidney Transplant; Complications Clinical Trial
Official title:
Evaluation of Nephrectomy Specimen to Verify a Mechanism of Intracranial Aneurysm Development in Autosomal Dominant Polycystic Kidney Disease Patients
ADPKD is the most common form of hereditary kidney disease and is known to occur in 1 of 400
to 1000 population in the U.S. ADPKD consists of 2.8% of patients receiving kidney
transplantation in the investigator's center. It is known that ADPKD is associated with
vascular anomalies, including abdominal aneurysms, valvular anomalies and especially
intracranial aneurysms. Intracranial aneurysms occur in 9~12% of the ADPKD population which
is higher than 2~3% in the general population and is known to be associated with PKD1 or PKD2
heritage.
Until now, most of the studies regarding intracranial aneurysms in ADPKD are conducted in
animal models, and there are only few cellular studies conducted from human samples. Total
154 patients received kidney transplantation for ADPKD from 1994 to December 2018 at Asan
Medical Center, Seoul, Korea. While performing kidney transplantation to ESRD ADPKD patients,
nephrectomy has been routinely performed for polycystic kidney and the nephrectomy specimens
can be obtained. The objective of this study is to investigate the mechanism of intracranial
aneurysm in ADPKD patients by analyzing gene characteristics from nephrectomy specimens.
ADPKD is associated with PKD1 gene on chromosome 16 and PKD2 gene on chromosome 4 and these
gene respectively code polycystin 1 and polycystin 2. Currently the hypotheses for increased
intracranial aneurysm rate in ADPKD patients is that mutation of polycystin is not only
confined to nephron tissues but also in endothelial cells and vascular smooth muscle cells
and results in mutation of vascular phenotype. Also recent studies show polycystin complex
causes cystic changes through mutation in primary cilia in renal epithelium. Wild type
endothelial cells respond to fluid shear stress by regulating levels of intracellular calcium
and nitric oxide, however, PKD1 or PKD2 mutation in fetal aortic endothelial cells revealed
loss of these responses.
During kidney transplantation, bilateral nephrectomies are routinely performed to ADPKD
patients. In this study, the investigators plan to perform PKD gene tests and gene sequencing
from polycystic kidney nephrectomy specimens of154 ADPKD patients who received kidney
transplantation at Asan Medical Center between 1994 and 2018. The aim of this study to
analyze the gene mutation of ADPKD patients and investigate mechanisms associated with
intracranial aneurysm occurence in ADPKD patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04369456 -
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
|
N/A | |
Recruiting |
NCT06001320 -
De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip
|
Early Phase 1 | |
Withdrawn |
NCT04560582 -
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
|
||
Not yet recruiting |
NCT05782543 -
Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion
|
N/A | |
Completed |
NCT03996551 -
ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study
|
N/A | |
Recruiting |
NCT05081141 -
HHV8 and Solid Organ Transplantation
|
||
Recruiting |
NCT04508907 -
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
|
Phase 4 | |
Recruiting |
NCT06440330 -
Define Predictors for Posttransplant Diabetes Mellitus Study
|
||
Not yet recruiting |
NCT06025240 -
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
|
||
Recruiting |
NCT04713774 -
Bone Density and Vascular Calcifications Evolution After Renal Transplant
|
||
Active, not recruiting |
NCT05483725 -
Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.
|
||
Recruiting |
NCT06095492 -
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
|
N/A | |
Active, not recruiting |
NCT04207177 -
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
|
Phase 4 | |
Recruiting |
NCT03410654 -
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
|
Early Phase 1 | |
Completed |
NCT03373266 -
Serun Fluoride and Kidney Transplant
|
Phase 2 | |
Completed |
NCT04835948 -
Efficacy of Single Dose Anti-thymocyte Globulin in the Modulation of T Lymphocytes in Kidney Transplantation
|
||
Not yet recruiting |
NCT04514666 -
VOCs in Kidney and Liver Transplants
|
N/A | |
Recruiting |
NCT03373500 -
Effect of Dietary Salt Reduction on Blood Pressure in Kidney Transplant Recipients
|
N/A | |
Recruiting |
NCT05900401 -
Delayed Tolerance Through Mixed Chimerism
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05166460 -
Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation
|
N/A |